the First Affiliated Hospital of Chongqing Medical Collage
Welcome,         Profile    Billing    Logout  
 11 Trials 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wu, Aiwen
NCT03448549: SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Recruiting
3
1191
RoW
Oxaliplatin, Tegafur，gimeracil and oteracil potassium, Xeloda, Capecitabine
Peking University Cancer Hospital & Institute, Peking Union Medical College Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking University People's Hospital
Colorectal Cancer Stage III, Adjuvant Chemotherapy
01/21
01/24
HATCHED, NCT03716518: Herbal Treatment to Improve Chemotherapy Delivery

Recruiting
3
400
RoW
Tonifying Spleen and Kidney Sequential Regimen, TSKSR, Placebo of 'Tonifying Spleen and Kidney Sequential Regimen, Placebo of TSKSR
Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Peking University Third Hospital, Beijing Chao Yang Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, Shanghai Zhongshan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Tianjin Union Medical Center, Henan Provincial People's Hospital, Zhengzhou Hospital of Traditional Chinese Medicine, Peking University Cancer Hospital & Institute, Chongqing University Cancer Hospital, Civil Aviation General Hospital
Colon Cancer
05/21
05/21
EPAC1, NCT03199989: Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors

Recruiting
3
1254
RoW
CapeOX（Capecitabine+Oxaliplatin）, Observation
Peking University Cancer Hospital & Institute, Peking Union Medical College Hospital, Peking University People's Hospital
Adjuvant Chemotherapy
07/21
07/24
NCT06229041: Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)

Recruiting
3
472
RoW
Camrelizumab ＋Immunotherapy
Peking University Cancer Hospital & Institute, Beijing Nanjiao Cancer Hospital
Rectal Cancer
10/27
10/29
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

Recruiting
3
688
RoW
Radical colectomy, HIPEC, Systemic chemotherapy
Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University
Colorectal Cancer
04/24
04/26
PKUCH-R04, NCT04340401: Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

Recruiting
2
25
RoW
SHR-1210, Camrelizumab, Oxaliplatin, OXA, Capecitabine, CAPE, Intensity modulated radiotherapy, IMRT, Total mesorectal excision, TME
Beijing Cancer Hospital
Rectal Cancer
07/20
04/22
NCT04296240: Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer

Recruiting
2
119
RoW
Oxaliplatin and capecitabine, antiemetics, Total Mesorectal Excision, TME
Peking University Cancer Hospital & Institute
Rectal Cancer
04/21
04/24
RCT, NCT04749381: The Role of TCM on ERAS of Rectal Cancer Patients

Recruiting
2
264
RoW
acupoint with TCM, acupoint with placebo
Beijing Cancer Hospital
Rectal Cancer
12/22
02/23
BJCC-R01, NCT04405206: Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer

Recruiting
2
54
RoW
Oxaliplatin, OXA, Capecitabine, Cape, intensity modulated radiotherapy, IMRT, DRE-Endoscopy-MRI-CEA, Nonoperative Management, NOM, Local excision, LE, Total Mesorectal Excision, TME, Quality of Life Questionnaires, QLQ
Beijing Cancer Hospital
Rectum Cancer
12/23
12/23
POLAR-STAR, NCT05245474: Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer

Recruiting
2
186
RoW
Long-course chemoradiation, with or without Tislelizumab (PD-1 inhibitor)
Beijing Friendship Hospital, Beijing Chao Yang Hospital, Xuanwu Hospital, Beijing, Beijing Hospital, Peking Union Medical College Hospital, Peking University First Hospital, Peking University People's Hospital, Peking University Cancer Hospital & Institute, BeiGene
Locally Advanced Rectal Cancer
03/24
09/29
NCT06135571: Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer

Recruiting
N/A
3000
RoW
Laparoscopic colorectal surgery
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Peking University Cancer Hospital & Institute, China-Japan Friendship Hospital, Chinese PLA General Hospital
Colorectal Cancer, Lymph Node Metastasis
09/24
09/26
NCT06146946: Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Not yet recruiting
N/A
1384
RoW
Dissection of the No.253 lymph node, Omitting the dissection of the No.253 lymph node
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, China-Japan Friendship Hospital, Chinese PLA General Hospital, Ruijin Hospital, Fudan University, West China Hospital, Peking University Cancer Hospital & Institute
Rectal Cancer
12/26
12/29
NCT05280210: PTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor

Not yet recruiting
N/A
420
NA
PTC drug screening
Peking University
Gastrointestinal Neoplasms
12/23
12/24
NCT06204497: The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients

Recruiting
N/A
570
RoW
Stent-based Diverting Technique
Sir Run Run Shaw Hospital
Rectal Neoplasms
12/24
06/25
NCT05923255: LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer

Recruiting
N/A
568
RoW
LISH （Laparoscopic Ileocecal-Sparing Right Hemicolectomy）, TRH（Traditional Laparoscopic Right Hemicolectomy）
Zhejiang University
Hepatic Flexure Colon Cancer, Proximal Transverse Colon Cancer
05/26
05/31
CTAC, NCT05529615: Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer

Recruiting
N/A
2684
RoW
detection of ctDNA
Peking University Cancer Hospital & Institute
Colon Cancer, Circulating Tumor DNA
05/29
05/29
Wei, Zhengqiang
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

Recruiting
3
688
RoW
Radical colectomy, HIPEC, Systemic chemotherapy
Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University
Colorectal Cancer
04/24
04/26
NCT05923255: LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer

Recruiting
N/A
568
RoW
LISH （Laparoscopic Ileocecal-Sparing Right Hemicolectomy）, TRH（Traditional Laparoscopic Right Hemicolectomy）
Zhejiang University
Hepatic Flexure Colon Cancer, Proximal Transverse Colon Cancer
05/26
05/31

Download Options